The integration enhances multimodal brain monitoring by streamlining EEG data access, visualization, and clinical decision-making in critical care environments....
As regulatory shifts accelerate, next-generation non-animal models must rapidly evolve to ensure safety, efficacy, and innovation in human drug development....
How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development. ...
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets ...
New AI-Enabled Technology Aims to Personalize Fluid Management and Improve Outcomes Across Hospital Network...
Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making ...
Patent strengthens company’s IP portfolio as it expands innovative treatments for chronic pain, oncology, and other high-need conditions ...
Recognition highlights breakthrough technology designed to enhance continuous, child-friendly monitoring in clinical and home settings...
New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy...
Approval now includes children as young as two, pregnant individuals, and people with type 2 diabetes across Europe...
